Atopic dermatitis atopic eczema
Conditions
Interventions
None listed
Sponsors
Academisch Medisch Centrum
Eligibility
Age
2 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients with atopic dermatitis participating in the TREAT NL registry. Patients can be part of the TREAT NL registry if they have atopic dermatitis AND start with a systemic immunomodulating treatment or phototherapy in the context op standard patient care
Exclusion criteria
Exclusion criteria: No participation in the TREAT NL registry, patients not recieving systemic immunomodulating treatment or phototherapy as treatment for their eczema
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The combined efforts of BIOMAP will support the definition of endotypes, i.e. a more precise disease classification, a definition of biomarkers enabling patient stratification and patient-directed care strategies, and the early identification of the most suitable therapy for every patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| BIOMAP will also stimulate future research on mechanisms and innovative treatments directed at endotype components. | — |
Countries
Netherlands
Outcome results
None listed